Literature DB >> 9513639

South African asbestos: production, exports, and destinations, 1959-1993.

J S Harington1, N D McGlashan.   

Abstract

Production and export figures of South African asbestos were analyzed over 1959-1993. They show stable sales of chrysotile. Those of crocidolite and amosite reached their peaks in the mid-1970s, after which trade fell drastically, crocidolite to 5% of its earlier peak and amosite to nil. Factors responsible for these virtual collapses were health issues, stricter legislation in First World countries, and litigation. In 1992, 21 countries continued to import crocidolite, although in reduced quantities. In the early 1960s, Europe and North America were the major recipients of South African asbestos. By 1989-91, these regions were surpassed by the Far East, which took over 90% of chrysotile and 70% of amosite. For crocidolite at that time, the Middle East took nearly 40%, Europe 28%, and Africa 21%. This implies that the newly importing countries can confidently expect an increase in asbestos-related disease and death well into the twenty-first century, even if the trade ceased now.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9513639     DOI: 10.1002/(sici)1097-0274(199804)33:4<321::aid-ajim2>3.0.co;2-x

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  4 in total

1.  A call for an international ban on asbestos.

Authors:  J LaDou; P Landrigan; J C Bailar; V Foa; A Frank
Journal:  CMAJ       Date:  2001-02-20       Impact factor: 8.262

2.  Risk of mesothelioma from exposure to crocidolite asbestos: a 1995 update of a South African mortality study.

Authors:  D Kielkowski; G Nelson; D Rees
Journal:  Occup Environ Med       Date:  2000-08       Impact factor: 4.402

Review 3.  Health effects of asbestos and nonasbestos fibers.

Authors:  O Y Osinubi; M Gochfeld; H M Kipen
Journal:  Environ Health Perspect       Date:  2000-08       Impact factor: 9.031

4.  Asbestos: use, bans and disease burden in Europe.

Authors:  Takashi Kameda; Ken Takahashi; Rokho Kim; Ying Jiang; Mehrnoosh Movahed; Eun-Kee Park; Jorma Rantanen
Journal:  Bull World Health Organ       Date:  2014-09-17       Impact factor: 9.408

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.